Role of Probiotics as Adjuvant Therapy in Newly Diagnosed Immune Thrombocytopenia in Childre

Phase 3

• Conditions: Haematological Disorders; Paediatrics

• Registration Number: PACTR202311873054587
• Lead Sponsor: Faculty of Medicine Tanta University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-07
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children aged 1–18 years with primary ITP having platelet count <30,000 /µL

Exclusion Criteria

Patients with secondary ITP including leukemia, drugs, lupus erythematous, cirrhosis, HIV, hepatitis C, antiphospholipid syndrome, von-Willebrand factor deficiency.
Previous probiotic or antibiotic treatment for the past 4 weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
early response, initial response, and durable response and remission rates in both groups

Secondary Outcome Measures

Name	Time	Method
bleeding score , steroid related side effects